Skip over main navigation
  • Log in
  • Basket: (0 items)
Hepatitis Australia
Listen
  • Search
  • Instagram
  • Twitter
  • Facebook
  • YouTube
Info line  Donate
Menu
  • About us
    • Who we are
    • Our Team
    • Our Board
    • Our Members
    • Corporate documents
    • Our website
    • Contacting Us
  • Hepatitis information
    • Liver Health
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis Statistics
    • Other Languages
  • How to get help
    • COVID-19
    • Hepatitis Infoline
    • Your Rights and Responsibilities
    • For friends and family
    • Local hepatitis organisations
  • Get involved
    • Donate
    • Share your story
  • Our work
    • Hepatitis B Program
    • Hepatitis C Program
    • Policy and Advocacy
    • Our publications
    • World Hepatitis Day
    • If tatts could talk
  • News
    • Latest News
    • Media Releases
  • Workforce
    • Community
    • Professionals
    • Training Opportunities
  • Admin
    • Log in
  • Basket: (0 items)
  1. News
  2. Latest News

News

Hepatitis Australia monitors for news articles which have relevance to hepatitis B or hepatitis C in Australia. From time-to-time we also issue public statements  and media releases which will also be shared here.

Parliamentary Morning Tea: We can eliminate hepatitis C!

Parliamentary Morning Tea: We can eliminate hepatitis C!

The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November. Read more

Published: 4th November, 2020

Updated: 6th November, 2020

Author: Grace Hogan

Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November. Read more

Published: 29th October, 2020

Updated: 30th October, 2020

Author: Grace Hogan

Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground. Read more

Published: 6th October, 2020

Updated: 7th October, 2020

Author: Grace Hogan

Investment in liver cancer medicines matched with prevention are changing Australian lives

Investment in liver cancer medicines matched with prevention are changing Australian lives

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS). Read more

Published: 6th October, 2020

Updated: 7th October, 2020

Author: Grace Hogan

2020 Nobel Prize awarded for discovery of hepatitis C virus

2020 Nobel Prize awarded for discovery of hepatitis C virus

6 October 2020 - Hepatitis Australia is celebrating the news that the Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice ‘for the discovery of Hepatitis C virus’. Read more

Published: 6th October, 2020

Updated: 7th October, 2020

Author: Grace Hogan

Not seeking help may place your health, or your life, at risk.

Not seeking help may place your health, or your life, at risk.

Patient safety and continuity of care is extremely important, particularly for people who have chronic and complex diseases or conditions, which is why Hepatitis Australia has joined the Continuity of Care Collaboration Read more

Published: 30th September, 2020

Updated: 12th October, 2020

Author: Kevin Marriott

Australian First for Network Nurse

Australian First for Network Nurse

22 September 2020: Hepatology Nurse Practitioner, Tracey Jones, has become the first Australian nurse to be awarded the Associate Fellow designation from the American Association for the Study of Liver Diseases Read more

Published: 22nd September, 2020

Author: Kevin Marriott

Let’s Talk Hep on World Hepatitis Day – 28 July

Let’s Talk Hep on World Hepatitis Day – 28 July

As Australia grapples with COVID-19 outbreaks, it is important to remember that viral hepatitis is also a pandemic. Viral hepatitis can lead to liver cancer and directly impacts nearly 360,000 people in Australia. Read more

Published: 28th July, 2020

Updated: 20th August, 2020

Author: Kevin Marriott

Leading organisations unite to discuss COVID-19 impact on hepatitis C elimination in Australia on World Hepatitis Day

Leading organisations unite to discuss COVID-19 impact on hepatitis C elimination in Australia on World Hepatitis Day

24 July 2020 - Australia’s leading drug and infectious disease organisations will join forces to call for a re-engagement in elimination of hepatitis C in an online event on World Hepatitis Day, Tuesday, 28 July 2020. Read more

Published: 24th July, 2020

Author: Kevin Marriott

Hepatitis C outbreak ignites debate on needle exchange in Queensland correctional centres

Hepatitis C outbreak ignites debate on needle exchange in Queensland correctional centres

23 July 2020 - Except from article from ABC Far North about hepatitis C outbreak in Queensland correctional centre. Read more

Published: 23rd July, 2020

Author: Kevin Marriott

Nurse Practitioner (s100) Prescribing Change

Nurse Practitioner (s100) Prescribing Change

Recent changes to the Pharmaceutical Benefits Scheme (PBS) allows authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Read more

Published: 1st April, 2020

Updated: 6th April, 2020

Author: Danny Adams

Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

Hepatitis Australia has put together a brief factsheet with information about the coronavirus COVID-19 for people living with hepatitis B and hepatitis C. Read more

Published: 10th March, 2020

Updated: 2nd April, 2020

Author: Danny Adams

Hepatitis Australia appoints new CEO

Hepatitis Australia appoints new CEO

04 March 2020 - Hepatitis Australia announces appointment of new CEO Read more

Published: 4th March, 2020

Author: Kevin Marriott

PBAC wants price reduction from HCV companies

PBAC wants price reduction from HCV companies

The Pharmaceutical Benefits Advisory Committee will consider loosening the prescribing authority for PBS-listed hepatitis C medicines but the real focus seems to be on securing a price reduction. Read more

Published: 2nd March, 2020

Updated: 3rd March, 2020

Author: Danny Adams

New President to lead the Board of Hepatitis Australia

New President to lead the Board of Hepatitis Australia

17 January 2020 - Hepatitis Australia announces Grant Phelps as the new President of the Board. Read more

Published: 16th January, 2020

Author: Kevin Marriott

Coalition of liver associations call for simplifying hepatitis C care

Coalition of liver associations call for simplifying hepatitis C care

14 November 2019: Leaders of liver disease associations from Europe, the United States, Latin America and Asia issued a global call to action at AASLD, aiming to advance toward the goal of eliminating hepatitis C as a public health threat. Read more

Published: 14th November, 2019

Author: Kevin Marriott

Praise for departing Hepatitis Australia CEO

Praise for departing Hepatitis Australia CEO

4 November 2019: Praise for the CEO of Hepatitis Australia Helen Tyrrell who has announced her intention to retire from the organisation she has led since 2005 Read more

Published: 3rd November, 2019

Author: Kevin Marriott

Guards say they want supervised injection sites in federal prisons

Guards say they want supervised injection sites in federal prisons

4 November 2019: OTTAWA; Setting up supervised injection sites at federal institutions is the way to go says the Union of Canadian Correctional Officers. Read more

Published: 3rd November, 2019

Author: Kevin Marriott

We have a vaccine for hepatitis B but here’s why we still need a cure

We have a vaccine for hepatitis B but here’s why we still need a cure

25 October 2019 - this article from The Conversation looks at why it is important to find a cure for hepatitis B, even when there is a vaccine available. Read more

Published: 25th October, 2019

Author: Kevin Marriott

NSW: Hepatitis A outbreak linked to imported clams

NSW: Hepatitis A outbreak linked to imported clams

19 September 2019: The NSW Food Authority issues food recall warning due to possible hepatitis A outbreak link to imported clams. Read more

Published: 19th September, 2019

Author: Kevin Marriott

World Hepatitis Alliance and IAPAC Announce Fast-Track Cities Partnership

World Hepatitis Alliance and IAPAC Announce Fast-Track Cities Partnership

10 September 2019 - The World Hepatitis Alliance (WHA) and the International Association of Providers of AIDS Care (IAPAC) announced a new partnership today on the first day of theFast-Track Cities 2019 conference in London. Read more

Published: 9th September, 2019

Author: Kevin Marriott

Changes to immigration health requirement a positive move for migrants with hepatitis B

Changes to immigration health requirement a positive move for migrants with hepatitis B

21 August 2019 - Changes to the immigration health requirement will have a significant and positive impact for people with hepatitis B seeking to migrate permanently to Australia. Read more

Published: 21st August, 2019

Updated: 3rd September, 2019

Author: Grace Hogan

Steep declines in hep C among people who inject drugs show Australia’s treatment for all approach is working

Steep declines in hep C among people who inject drugs show Australia’s treatment for all approach is working

25 July 2019 - Hepatitis C has declined by a staggering 60% among people who inject drugs since new hepatitis C cures were made available Read more

Published: 25th July, 2019

Updated: 3rd September, 2019

Author: Kevin Marriott

World Hepatitis Day – Australians still missing out on care.

World Hepatitis Day – Australians still missing out on care.

25 July 2019 - We are encouraging people to take a short quiz to see if they may have been at risk of hepatitis in the past and whether they should talk to their doctor about hepatitis Read more

Published: 25th July, 2019

Updated: 3rd September, 2019

Author: Kevin Marriott

Load more Back to top

Showing 10 of 42

Latest

  • Parliamentary Morning Tea: We can eliminate hepatitis C!

    Parliamentary Morning Tea: We can eliminate hepatitis C!

    The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November.

  • Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

    Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

    The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November.

  • Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

    Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

    6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground.

  • Investment in liver cancer medicines matched with prevention are changing Australian lives

    Investment in liver cancer medicines matched with prevention are changing Australian lives

    6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS).

Most read

  • Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

    Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

    Hepatitis Australia has put together a brief factsheet with information about the coronavirus COVID-19 for people living with hepatitis B and hepatitis C.

  • COVID-19

    COVID-19

    Information on the coronavirus COVID-19 for people affected by hepatitis B or hepatitis C.

  • Hepatitis A

    Basic information about hepatitis A in Australia

  • A cure for hepatitis C

    A cure for hepatitis C

    Highly effective medicines are now available in Australia to cure hepatitis C

  • Hepatitis B and relationships

    Hepatitis B and relationships

    Although most people get hepatitis B at birth, it can be transmitted in other ways including sex. This article contains information about how it is spreads, and how you can keep your partner safe.

  • What is hepatitis C?

    What is hepatitis C?

    Basic information about hepatitis C and how it can effect you.

  • Hepatitis B treatment

    Hepatitis B treatment

    Who needs treatment for hepatitis B and what is involved.

  • Hepatitis B vaccination

    Hepatitis B vaccination

    Hepatitis B can be prevented with a safe and effective vaccine.

  • Accessibility

  • Changes to immigration health requirement a positive move for migrants with hepatitis B

    Changes to immigration health requirement a positive move for migrants with hepatitis B

    21 August 2019 - Changes to the immigration health requirement will have a significant and positive impact for people with hepatitis B seeking to migrate permanently to Australia.

Join our mailing list

Interests

Info

Hepatitis Australia is a registered charity. 
ABN: 38 442 686 487

© Copyright 2019 Hepatitis Australia.
All rights reserved.
View our copyright statement here

Helpful links

  • Contact us
  • Full sitemap
  • Accessibillity
  • Terms & conditions
  • Privacy policy
  • Login
  • Logout
  • Manager

Member sites

  • Australian Capital Territory
  • New South Wales
  • Northern Territory
  • South Australia
  • Victoria
  • Queensland
  • Western Australia
  • Tasmania 

Information provided on this website is for general information only and not intended as medical advice. Hepatitis Australia encourages all readers to seek independent medical advice before making any decisions based on the information provided on this website.

Hepatitis Australia is a partner organisation of healthdirect Australia.
healthdirect - trusted health advice

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.
Search only trustworthy HONcode health websites: 

Images used on this site may include stock photos and the associated messaging may not represent the personal situation, views or beliefs of the people in the images.